Global Hepatitis B Vaccine Consumption- Market

Hepatitis B Vaccine Consumption- Comprehensive Study by Type (Single Antigen, Combination), Distribution Channel (Hospitals, Vaccination Centres, Specialty Clinics, Government Suppliers, Others), Dose (Two, Three), End User (Infants, Pediatric, Adults) Players and Region - Global Market Outlook to 2028

Hepatitis B Vaccine Consumption- Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Hepatitis B Vaccine Consumption- Market Scope
The hepatitis B vaccine is a vaccine designed to protect against the hepatitis B virus (HBV). The vaccine contains the hepatitis B surface antigen (HBsAg) and the viral envelope protein. This immunization strengthens the immune system and produces anti-HBsAg antibodies. Hepatitis B infection is becoming more common worldwide, driving the industry forward. Due to the increase in the number of hepatitis B infection cases, the global hepatitis B vaccine market is growing rapidly.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledGSK plc (United Kingdom), Dynavax Technologies Corporation (United States), VBI Vaccines Inc. (United States), Sanofi S.A. (France), Merck & Co., Inc. (United States), Novartis AG (Switzerland), Serum Institute of India Pvt. Ltd. (India), Beijing Minhai Biological Technology Co., Ltd. (China), CSL Limited (Australia) and Sinovac Biotech Ltd. (China)
CAGR%


Continued investment in research and development can help manufacturers stay ahead of the competition by developing new vaccines with improved efficacy, safety, or convenience. Apart from this, manufacturers can leverage strategic partnerships and collaborations with other companies or research organizations to gain access to new technologies, expand their market reach, or improve their manufacturing processes.

GSK plc (United Kingdom), Dynavax Technologies Corporation (United States), VBI Vaccines Inc. (United States), Sanofi S.A. (France), Merck & Co., Inc. (United States), Novartis AG (Switzerland), Serum Institute of India Pvt. Ltd. (India), Beijing Minhai Biological Technology Co., Ltd. (China), CSL Limited (Australia) and Sinovac Biotech Ltd. (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Gilead Sciences, Inc. (United States) and Shenzhen Kangtai Biological Products (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Hepatitis B Vaccine Consumption- market by Type and Region with country level break-up.

On the basis of geography, the market of Hepatitis B Vaccine Consumption- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In August 2021, Sanofi announced the acquisition of Bio Inc. to accelerate the applicability of mRNA technology in the research and development of new vaccines. This strategic acquisition advanced the company's R & D facility and improved the productivity of manufactured products.

In the United States, the FDA is the regulatory authority responsible for evaluating and approving vaccines, including the hepatitis B vaccine. The FDA ensures that vaccines meet safety, efficacy, and quality standards before they can be marketed and distributed in the United States.

Influencing Trend:
Use of AI In Vaccine and Drug Design

Market Growth Drivers:
Rising Prevalence of HBV Infection, Increasing Healthcare Expenditure and Extensive Investments In R&D By Major Industry Players

Challenges:
High Cost of Vaccine Development

Restraints:
Stringent Regulatory Policies for Vaccine Approval

Opportunities:
Rising Global Awareness and Immunization Initiatives and Favorable Government Initiatives and Policies

Key Target Audience
Vaccine Manufacturers, Government Institutes, Potential Investors, Education & Research Institutes, Regulatory Bodies, Market Research & Consulting Firms and Others

Report Objectives / Segmentation Covered

By Type
  • Single Antigen
  • Combination

By Distribution Channel
  • Hospitals
  • Vaccination Centres
  • Specialty Clinics
  • Government Suppliers
  • Others

By Dose
  • Two
  • Three

By End User
  • Infants
  • Pediatric
  • Adults

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of HBV Infection
      • 3.2.2. Increasing Healthcare Expenditure
      • 3.2.3. Extensive Investments In R&D By Major Industry Players
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Vaccine Development
    • 3.4. Market Trends
      • 3.4.1. Use of AI In Vaccine and Drug Design
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hepatitis B Vaccine Consumption-, by Type, Distribution Channel, Dose, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Hepatitis B Vaccine Consumption- (Value)
      • 5.2.1. Global Hepatitis B Vaccine Consumption- by: Type (Value)
        • 5.2.1.1. Single Antigen
        • 5.2.1.2. Combination
      • 5.2.2. Global Hepatitis B Vaccine Consumption- by: Type (Value)
        • 5.2.2.1. Single Antigen
        • 5.2.2.2. Combination
      • 5.2.3. Global Hepatitis B Vaccine Consumption- by: Distribution Channel (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Vaccination Centres
        • 5.2.3.3. Specialty Clinics
        • 5.2.3.4. Government Suppliers
        • 5.2.3.5. Others
      • 5.2.4. Global Hepatitis B Vaccine Consumption- by: Dose (Value)
        • 5.2.4.1. Two
        • 5.2.4.2. Three
      • 5.2.5. Global Hepatitis B Vaccine Consumption- by: End User (Value)
        • 5.2.5.1. Infants
        • 5.2.5.2. Pediatric
        • 5.2.5.3. Adults
      • 5.2.6. Global Hepatitis B Vaccine Consumption- Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Hepatitis B Vaccine Consumption-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GSK plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dynavax Technologies Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. VBI Vaccines Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sanofi S.A. (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Serum Institute of India Pvt. Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Beijing Minhai Biological Technology Co., Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CSL Limited (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sinovac Biotech Ltd. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Hepatitis B Vaccine Consumption- Sale, by Type, Distribution Channel, Dose, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Hepatitis B Vaccine Consumption- (Value)
      • 7.2.1. Global Hepatitis B Vaccine Consumption- by: Type (Value)
        • 7.2.1.1. Single Antigen
        • 7.2.1.2. Combination
      • 7.2.2. Global Hepatitis B Vaccine Consumption- by: Type (Value)
        • 7.2.2.1. Single Antigen
        • 7.2.2.2. Combination
      • 7.2.3. Global Hepatitis B Vaccine Consumption- by: Distribution Channel (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Vaccination Centres
        • 7.2.3.3. Specialty Clinics
        • 7.2.3.4. Government Suppliers
        • 7.2.3.5. Others
      • 7.2.4. Global Hepatitis B Vaccine Consumption- by: Dose (Value)
        • 7.2.4.1. Two
        • 7.2.4.2. Three
      • 7.2.5. Global Hepatitis B Vaccine Consumption- by: End User (Value)
        • 7.2.5.1. Infants
        • 7.2.5.2. Pediatric
        • 7.2.5.3. Adults
      • 7.2.6. Global Hepatitis B Vaccine Consumption- Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hepatitis B Vaccine Consumption-: by Type(USD Million)
  • Table 2. Hepatitis B Vaccine Consumption- Single Antigen , by Region USD Million (2017-2022)
  • Table 3. Hepatitis B Vaccine Consumption- Combination , by Region USD Million (2017-2022)
  • Table 4. Hepatitis B Vaccine Consumption-: by Type(USD Million)
  • Table 5. Hepatitis B Vaccine Consumption- Single Antigen , by Region USD Million (2017-2022)
  • Table 6. Hepatitis B Vaccine Consumption- Combination , by Region USD Million (2017-2022)
  • Table 7. Hepatitis B Vaccine Consumption-: by Distribution Channel(USD Million)
  • Table 8. Hepatitis B Vaccine Consumption- Hospitals , by Region USD Million (2017-2022)
  • Table 9. Hepatitis B Vaccine Consumption- Vaccination Centres , by Region USD Million (2017-2022)
  • Table 10. Hepatitis B Vaccine Consumption- Specialty Clinics , by Region USD Million (2017-2022)
  • Table 11. Hepatitis B Vaccine Consumption- Government Suppliers , by Region USD Million (2017-2022)
  • Table 12. Hepatitis B Vaccine Consumption- Others , by Region USD Million (2017-2022)
  • Table 13. Hepatitis B Vaccine Consumption-: by Dose(USD Million)
  • Table 14. Hepatitis B Vaccine Consumption- Two , by Region USD Million (2017-2022)
  • Table 15. Hepatitis B Vaccine Consumption- Three , by Region USD Million (2017-2022)
  • Table 16. Hepatitis B Vaccine Consumption-: by End User(USD Million)
  • Table 17. Hepatitis B Vaccine Consumption- Infants , by Region USD Million (2017-2022)
  • Table 18. Hepatitis B Vaccine Consumption- Pediatric , by Region USD Million (2017-2022)
  • Table 19. Hepatitis B Vaccine Consumption- Adults , by Region USD Million (2017-2022)
  • Table 20. South America Hepatitis B Vaccine Consumption-, by Country USD Million (2017-2022)
  • Table 21. South America Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 22. South America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 23. South America Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 24. South America Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 25. Brazil Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 26. Brazil Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 27. Brazil Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 28. Brazil Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 29. Argentina Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 30. Argentina Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 31. Argentina Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 32. Argentina Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 33. Rest of South America Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 34. Rest of South America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 35. Rest of South America Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 36. Rest of South America Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 37. Asia Pacific Hepatitis B Vaccine Consumption-, by Country USD Million (2017-2022)
  • Table 38. Asia Pacific Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 39. Asia Pacific Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 40. Asia Pacific Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 41. Asia Pacific Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 42. China Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 43. China Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 44. China Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 45. China Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 46. Japan Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 47. Japan Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 48. Japan Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 49. Japan Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 50. India Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 51. India Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 52. India Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 53. India Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 54. South Korea Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 55. South Korea Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 56. South Korea Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 57. South Korea Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 58. Taiwan Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 59. Taiwan Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 60. Taiwan Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 61. Taiwan Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 62. Australia Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 63. Australia Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 64. Australia Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 65. Australia Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 70. Europe Hepatitis B Vaccine Consumption-, by Country USD Million (2017-2022)
  • Table 71. Europe Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 72. Europe Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 73. Europe Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 74. Europe Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 75. Germany Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 76. Germany Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 77. Germany Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 78. Germany Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 79. France Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 80. France Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 81. France Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 82. France Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 83. Italy Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 84. Italy Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 85. Italy Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 86. Italy Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 87. United Kingdom Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 88. United Kingdom Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 89. United Kingdom Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 90. United Kingdom Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 91. Netherlands Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 92. Netherlands Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 93. Netherlands Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 94. Netherlands Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 95. Rest of Europe Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 96. Rest of Europe Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 97. Rest of Europe Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 98. Rest of Europe Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 99. MEA Hepatitis B Vaccine Consumption-, by Country USD Million (2017-2022)
  • Table 100. MEA Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 101. MEA Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 102. MEA Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 103. MEA Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 104. Middle East Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 105. Middle East Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 106. Middle East Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 107. Middle East Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 108. Africa Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 109. Africa Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 110. Africa Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 111. Africa Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 112. North America Hepatitis B Vaccine Consumption-, by Country USD Million (2017-2022)
  • Table 113. North America Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 114. North America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 115. North America Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 116. North America Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 117. United States Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 118. United States Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 119. United States Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 120. United States Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 121. Canada Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 122. Canada Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 123. Canada Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 124. Canada Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 125. Mexico Hepatitis B Vaccine Consumption-, by Type USD Million (2017-2022)
  • Table 126. Mexico Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2017-2022)
  • Table 127. Mexico Hepatitis B Vaccine Consumption-, by Dose USD Million (2017-2022)
  • Table 128. Mexico Hepatitis B Vaccine Consumption-, by End User USD Million (2017-2022)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Hepatitis B Vaccine Consumption-: by Type(USD Million)
  • Table 140. Hepatitis B Vaccine Consumption- Single Antigen , by Region USD Million (2023-2028)
  • Table 141. Hepatitis B Vaccine Consumption- Combination , by Region USD Million (2023-2028)
  • Table 142. Hepatitis B Vaccine Consumption-: by Type(USD Million)
  • Table 143. Hepatitis B Vaccine Consumption- Single Antigen , by Region USD Million (2023-2028)
  • Table 144. Hepatitis B Vaccine Consumption- Combination , by Region USD Million (2023-2028)
  • Table 145. Hepatitis B Vaccine Consumption-: by Distribution Channel(USD Million)
  • Table 146. Hepatitis B Vaccine Consumption- Hospitals , by Region USD Million (2023-2028)
  • Table 147. Hepatitis B Vaccine Consumption- Vaccination Centres , by Region USD Million (2023-2028)
  • Table 148. Hepatitis B Vaccine Consumption- Specialty Clinics , by Region USD Million (2023-2028)
  • Table 149. Hepatitis B Vaccine Consumption- Government Suppliers , by Region USD Million (2023-2028)
  • Table 150. Hepatitis B Vaccine Consumption- Others , by Region USD Million (2023-2028)
  • Table 151. Hepatitis B Vaccine Consumption-: by Dose(USD Million)
  • Table 152. Hepatitis B Vaccine Consumption- Two , by Region USD Million (2023-2028)
  • Table 153. Hepatitis B Vaccine Consumption- Three , by Region USD Million (2023-2028)
  • Table 154. Hepatitis B Vaccine Consumption-: by End User(USD Million)
  • Table 155. Hepatitis B Vaccine Consumption- Infants , by Region USD Million (2023-2028)
  • Table 156. Hepatitis B Vaccine Consumption- Pediatric , by Region USD Million (2023-2028)
  • Table 157. Hepatitis B Vaccine Consumption- Adults , by Region USD Million (2023-2028)
  • Table 158. South America Hepatitis B Vaccine Consumption-, by Country USD Million (2023-2028)
  • Table 159. South America Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 160. South America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 161. South America Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 162. South America Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 163. Brazil Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 164. Brazil Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 165. Brazil Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 166. Brazil Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 167. Argentina Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 168. Argentina Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 169. Argentina Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 170. Argentina Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 171. Rest of South America Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 172. Rest of South America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 173. Rest of South America Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 174. Rest of South America Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 175. Asia Pacific Hepatitis B Vaccine Consumption-, by Country USD Million (2023-2028)
  • Table 176. Asia Pacific Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 177. Asia Pacific Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 178. Asia Pacific Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 179. Asia Pacific Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 180. China Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 181. China Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 182. China Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 183. China Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 184. Japan Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 185. Japan Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 186. Japan Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 187. Japan Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 188. India Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 189. India Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 190. India Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 191. India Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 192. South Korea Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 193. South Korea Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 194. South Korea Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 195. South Korea Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 196. Taiwan Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 197. Taiwan Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 198. Taiwan Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 199. Taiwan Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 200. Australia Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 201. Australia Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 202. Australia Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 203. Australia Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 204. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 205. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 206. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 207. Rest of Asia-Pacific Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 208. Europe Hepatitis B Vaccine Consumption-, by Country USD Million (2023-2028)
  • Table 209. Europe Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 210. Europe Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 211. Europe Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 212. Europe Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 213. Germany Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 214. Germany Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 215. Germany Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 216. Germany Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 217. France Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 218. France Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 219. France Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 220. France Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 221. Italy Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 222. Italy Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 223. Italy Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 224. Italy Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 225. United Kingdom Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 226. United Kingdom Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 227. United Kingdom Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 228. United Kingdom Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 229. Netherlands Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 230. Netherlands Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 231. Netherlands Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 232. Netherlands Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 233. Rest of Europe Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 234. Rest of Europe Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 235. Rest of Europe Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 236. Rest of Europe Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 237. MEA Hepatitis B Vaccine Consumption-, by Country USD Million (2023-2028)
  • Table 238. MEA Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 239. MEA Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 240. MEA Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 241. MEA Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 242. Middle East Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 243. Middle East Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 244. Middle East Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 245. Middle East Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 246. Africa Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 247. Africa Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 248. Africa Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 249. Africa Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 250. North America Hepatitis B Vaccine Consumption-, by Country USD Million (2023-2028)
  • Table 251. North America Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 252. North America Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 253. North America Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 254. North America Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 255. United States Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 256. United States Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 257. United States Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 258. United States Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 259. Canada Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 260. Canada Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 261. Canada Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 262. Canada Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 263. Mexico Hepatitis B Vaccine Consumption-, by Type USD Million (2023-2028)
  • Table 264. Mexico Hepatitis B Vaccine Consumption-, by Distribution Channel USD Million (2023-2028)
  • Table 265. Mexico Hepatitis B Vaccine Consumption-, by Dose USD Million (2023-2028)
  • Table 266. Mexico Hepatitis B Vaccine Consumption-, by End User USD Million (2023-2028)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hepatitis B Vaccine Consumption-: by Type USD Million (2017-2022)
  • Figure 5. Global Hepatitis B Vaccine Consumption-: by Type USD Million (2017-2022)
  • Figure 6. Global Hepatitis B Vaccine Consumption-: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Hepatitis B Vaccine Consumption-: by Dose USD Million (2017-2022)
  • Figure 8. Global Hepatitis B Vaccine Consumption-: by End User USD Million (2017-2022)
  • Figure 9. South America Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 10. Asia Pacific Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 11. Europe Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 12. MEA Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 13. North America Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 14. Global Hepatitis B Vaccine Consumption- share by Players 2022 (%)
  • Figure 15. Global Hepatitis B Vaccine Consumption- share by Players (Top 3) 2022(%)
  • Figure 16. Global Hepatitis B Vaccine Consumption- share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. GSK plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. GSK plc (United Kingdom) Revenue: by Geography 2022
  • Figure 20. Dynavax Technologies Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Dynavax Technologies Corporation (United States) Revenue: by Geography 2022
  • Figure 22. VBI Vaccines Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. VBI Vaccines Inc. (United States) Revenue: by Geography 2022
  • Figure 24. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 25. Sanofi S.A. (France) Revenue: by Geography 2022
  • Figure 26. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Novartis AG (Switzerland) Revenue: by Geography 2022
  • Figure 30. Serum Institute of India Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 31. Serum Institute of India Pvt. Ltd. (India) Revenue: by Geography 2022
  • Figure 32. Beijing Minhai Biological Technology Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 33. Beijing Minhai Biological Technology Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 34. CSL Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 35. CSL Limited (Australia) Revenue: by Geography 2022
  • Figure 36. Sinovac Biotech Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 37. Sinovac Biotech Ltd. (China) Revenue: by Geography 2022
  • Figure 38. Global Hepatitis B Vaccine Consumption-: by Type USD Million (2023-2028)
  • Figure 39. Global Hepatitis B Vaccine Consumption-: by Type USD Million (2023-2028)
  • Figure 40. Global Hepatitis B Vaccine Consumption-: by Distribution Channel USD Million (2023-2028)
  • Figure 41. Global Hepatitis B Vaccine Consumption-: by Dose USD Million (2023-2028)
  • Figure 42. Global Hepatitis B Vaccine Consumption-: by End User USD Million (2023-2028)
  • Figure 43. South America Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 44. Asia Pacific Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 45. Europe Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 46. MEA Hepatitis B Vaccine Consumption- Share (%), by Country
  • Figure 47. North America Hepatitis B Vaccine Consumption- Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GSK plc (United Kingdom)
  • Dynavax Technologies Corporation (United States)
  • VBI Vaccines Inc. (United States)
  • Sanofi S.A. (France)
  • Merck & Co., Inc. (United States)
  • Novartis AG (Switzerland)
  • Serum Institute of India Pvt. Ltd. (India)
  • Beijing Minhai Biological Technology Co., Ltd. (China)
  • CSL Limited (Australia)
  • Sinovac Biotech Ltd. (China)
Additional players considered in the study are as follows:
Gilead Sciences, Inc. (United States) , Shenzhen Kangtai Biological Products (China)
Select User Access Type

Key Highlights of Report


May 2023 229 Pages 93 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hepatitis B Vaccine Consumption- Market Quantitative research analysis
Global Hepatitis B Vaccine Consumption- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Hepatitis B Vaccine Consumption- Market are by end use application [].
The Hepatitis B Vaccine Consumption- Market is gaining popularity and expected to see strong valuation by 2028.
  • Rising Prevalence of HBV Infection
  • Increasing Healthcare Expenditure
  • Extensive Investments In R&D By Major Industry Players

Know More About Global Hepatitis B Vaccine Consumption- Market Report?

Have a Query? Click Here

Other Related Reports

Dendritic Cell Cancer Vaccine Industry Comprehensive Study by Type (CreaVax, Sipuleucel-T (Provenge), Others), Indication (Prostate Cancer, Brain Cancer, Liver Cancer, Others), Distribution Channel (...
$ 3800
Drive-through COVID-19 Testing Comprehensive Study by Type (Molecular Test, Antigen Test, Antibody Test), Application (Hospital, Residential area, Workplace, Others), Sample Type (Blood, Nasal swabs...
$ 3800
Next Generation Probiotics Comprehensive Study by Application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease, Others), Category (Akkermansia Muciniphila, Faecalibacterium Prausn...
$ 3800
Medical Manuka Honey Comprehensive Study by Application (Healthcare, Skin Care Industry, Others), Distribution Channel (Online, Offline), Category Type (K-Factor, K-Factor 12, K-Factor 16, K-Factor 2...
$ 3800
Digital Payment in Healthcare Comprehensive Study by Type (On-Premise, Cloud), By Enterprise size (Small size, Medium size, Large size), By Component (Solution, Service, Intelligence), Payment Mode...
$ 3800
Cell Therapy Market Comprehensive Study by Application (Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds, Other), Type (Autologous, Allogeneic), End User (Hospitals, Homecare, S...
$ 3800